Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Dihexa for Sale > High Purity Dihexa Peptide CAS 1401708-83-5 Brain-Penetrant Lyophilized Powder Bulk Supply With COA
High Purity Dihexa Peptide CAS 1401708-83-5 Brain-Penetrant Lyophilized Powder Bulk Supply With COA buy - large image1
High Purity Dihexa Peptide CAS 1401708-83-5 Brain-Penetrant Lyophilized Powder Bulk Supply With COA buy - image1
High Purity Dihexa Peptide CAS 1401708-83-5 Brain-Penetrant Lyophilized Powder Bulk Supply With COA buy - image2
High Purity Dihexa Peptide CAS 1401708-83-5 Brain-Penetrant Lyophilized Powder Bulk Supply With COA buy - image3
High Purity Dihexa Peptide CAS 1401708-83-5 Brain-Penetrant Lyophilized Powder Bulk Supply With COA buy - image4
High Purity Dihexa Peptide CAS 1401708-83-5 Brain-Penetrant Lyophilized Powder Bulk Supply With COA buy - image5
High Purity Dihexa Peptide CAS 1401708-83-5 Brain-Penetrant Lyophilized Powder Bulk Supply With COA buy - image6

High Purity Dihexa Peptide CAS 1401708-83-5 Brain-Penetrant Lyophilized Powder Bulk Supply With COA

TDS 162 Inquiries

Unit Price:

$40-50/UNIT EXW

Get Latest Price
CAS No.:

1401708-83-5

Grade:

Pharmaceutical Grade

Content:

99%

Port:

海南

Brand:

SDR

Packaging:

Bottled

Price valid (until):

2027-02-28

Company Type:
Trader
Location:
China
Qualification:
Main Products:

peptides,Semagiutide,Retatrutide,GHK-CU,MOTS-c,Semax

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Introduction  


    Items Specifications
    Packaging method Bottled
    Purity 99%
    Product abbreviation DI
    Dosage 10mg*10vials
    Dihexa, also known as PNB‑0408, is a synthetic angiotensin‑IV‑derived peptide compound with powerful blood‑brain‑barrier penetration and improved metabolic stabilitydihexa.co..... It acts as a high‑affinity potentiator targeting the HGF/c‑Met signaling complex, amplifying downstream PI3K/Akt and MAPK/ERK signaling cascades within neuronal cellsPeptide Bi.... This peptide supports neuronal survival, neurite outgrowth, dendritic spine formation and synaptogenesis, contributing to synaptic plasticity and neural network reconstruction. Pre‑research data indicates it exhibits potent bioactivity at picomolar concentrations, and it is widely applied in research related to cognitive function, age‑related neural decline, Alzheimer’s disease models and brain injury repair. The lyophilized Dihexa powder shows good storage stability. Each batch is verified by HPLC and mass spectrometry to guarantee product consistency for mechanism research and pre‑project exploration.


      Company Profile


    We are a high-tech enterprise dedicated to the research and development of innovative peptide compounds, customized synthesis and supply of scientific research raw materials. We are deeply involved in the fields of peptide chemical synthesis, purification processes and quality analysis, providing high-quality peptide research raw materials and technical support services to domestic and foreign university laboratories, pharmaceutical research institutions and CRO enterprises.
    The company has gathered professional technical teams specializing in peptide synthesis, analysis and testing, and process development. It has established a complete peptide synthesis laboratory, purification platform and quality control testing system, and possesses the capacity for large-scale preparation of long-chain peptides, modified peptides and novel target peptides. It can provide integrated technical support including solid-phase synthesis, liquid-phase synthesis, chromatographic purification, structural characterization and stability research.
    The core scientific research raw material product line covers GLP-1-related target peptides and various innovative active peptide intermediates, among which Retatrutide (LY3437943) is a scientific research grade peptide raw material. All products are for in vitro scientific research and experimental use only. They must not be used for human trials, clinical drug administration, medical aesthetics or any diagnostic or therapeutic purposes.
    The company has established a standardized quality control process. Each batch of raw materials is accompanied by HPLC purity testing and MS mass spectrometry structure verification reports, strictly controlling key indicators such as purity, impurities, and moisture. We can provide services such as repackaging in different specifications, customized synthesis, and process optimization, supporting the experimental needs of research institutions for the early-stage pharmacological research and mechanism exploration of new drug targets.
    Since its establishment, the enterprise has adhered to the concept of compliant operation, strictly abided by relevant laws and regulations on pharmaceutical research and development, and established long-term and stable cooperation with many domestic universities and drug research and development laboratories. With stable product quality, efficient delivery capabilities and professional technical consulting services, we support the basic research of innovative metabolic target drugs and continuously provide reliable raw material support for global peptide basic scientific research.


    Business philosophy


    Focus on the innovative research and development of peptides, strictly adhere to the boundaries of scientific research and application, prioritize quality, and achieve win-win results through integrity

    Contact information





    Email: 1060575270@qq.com

    W hatsapp:+852 5976 3637


      Product display 


    Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 1 Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 2 Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 3 Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 4 Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 5 Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 6 Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 7 Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 8 Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 9 Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 10  Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 11 Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 12 Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 13 Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 14 Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 15


    Certificates
    • High Purity Dihexa Peptide CAS 1401708-83-5 Brain-Penetrant Lyophilized Powder Bulk Supply With COA Certificates 1 TDS

    Basic Info
    Product Name:

    Dihexa

    Other Name:

    L-Isoleucinamide,N-(1-oxohexyl)-L-tyrosyl-N-(6-amino-6-oxohexyl)-;N-(1-Oxohexyl)-L-tyrosyl-N-(6-amino-6-oxohexyl)-L-isoleucinamide;Dihexa;N-Hexanoic-Tyr-Ile-(6)aminohexanoic amide

    CAS No.:

    1401708-83-5

    Molecular Formula:

    C27H44N4O5

    InChIKeys:

    InChIKey=XEUVNVNAVKZSPT-JTJYXVOQSA-N

    Molecular Weight:

    504.7

    Exact Mass:

    504.66

    Characteristics
    Density:

    1.111±0.06 g/cm3(Predicted)

    Boiling Point:

    866.2±65.0 °C(Predicted)

    Research
    Class:

    Angiotensin IV-derived oligopeptide / HGF-c-Met potentiator

    Status:

    Research compound — Not FDA approved

    Mechanism:

    A synthetic, orally active, blood-brain-barrier-permeable oligopeptide (Hexanoyl-Tyr-Ile-Ahx-NH₂) derived from angiotensin IV. Dihexa binds hepatocyte growth factor (HGF) with high affinity (Kd = 65 pM) and allosterically potentiates HGF activity at its receptor c-Met, promoting dendritic spinogenesis and synaptogenesis. In preclinical models it was reported to be seven orders of magnitude more potent than BDNF at promoting synapse formation. Note: the foundational 2014 paper (McCoy AT, et al. Neurobiol Learn Mem. 2014) was retracted in 2025.

    EC50 (HGF Binding KD):

    65 pM

    Activity note:

    Dihexa is an HGF potentiator, not a direct receptor agonist. It does not activate c-Met alone but markedly augments HGF-induced c-Met activation at low nanomolar HGF concentrations. Functional synaptogenic activity was reported at 10⁻¹°–10⁻⁻ M (original data now subject to retraction).

    Source:

    Original report: McCoy AT, et al. Neurobiol Learn Mem. 2014;115:112-120 (retracted 2025). Benoist CC, et al. J Pharmacol Exp Ther. 2014;351(3):628-637.

    Clinical Development:

    NCT04488419

    References
    PubChem:

    PubChem

    UNII:

    9WYX65A5C2

    Disclaimer:

    Dihexa is NOT FDA-approved or EMA-approved as a medicine. It is a research compound only. The foundational 2014 paper describing its synaptogenic potency was retracted in 2025. Its phosphate prodrug fosgonimeton failed a Phase 2/3 Alzheimer’s trial (LIFT-AD, 2024). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    peptides,Semagiutide,Retatrutide,GHK-CU,MOTS-c,Semax

    Location:

    Units 1503-14, 15th Floor, New HNA Building, No. 7 Guoxing Avenue, Lantian Subdistrict, Meilan District, Haikou City, Hainan Province

    Payment Terms:

    TT against copy of documents,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    3

    Total Annual Revenue:

    $2.5 million-$5 million

    Total Employees:

    101-200

    Year of Establishment:

    2025

  • Inquiry History
    162 Inquiries
    Country Product Purchase Quantity Date Posted
    Canada

    Dihexa 1401708-83-5

    1 G Mar 8, 2026
    Bulgaria

    Customized peptides high purity Dihexa with fast shipping door to door CAS 1401708-83-5

    10 G May 27, 2025
    United States

    Dihexa

    25 G Jan 26, 2025
    Russia

    DIHEXA

    50.00 G Aug 14, 2024
    Canada

    Dihexa

    130  Aug 12, 2026
    Brazil

    dihexa

    90 MG Aug 4, 2026
    United States

    Dihexa raw powder

    10 G Jul 26, 2026
    Singapore

    Dihexa

    10 PCS Jul 15, 2026
    United States

    Dihexa

    1 G Jul 11, 2026
    Sweden

    Dihexa

    10 PCS Jul 8, 2026
    Australia

    Dihexa

    1 MT Jul 2, 2026
    United States

    Dihexa

    10 G Jun 14, 2026
    Germany

    Dihexa

    1 G May 25, 2026
    Thailand

    Dihexa

    1 G May 12, 2026
    United States

    Dihexa

    100 G May 4, 2026
    Italy

    simona migliori

    10 MT Apr 23, 2026
    United States

    Dihexa

    10 G Apr 22, 2026
    United States

    Dihexa

    1 G Apr 22, 2026
    Ecuador

    DIHEXA

    10 PCS Apr 19, 2026
    United States

    dihexa

    10 MG Apr 13, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.